Programmatic evaluation of a combined antigen and antibody test for rapid HIV diagnosis in a community and sexual health clinic screening programme

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Taegtmeyer, Miriam ^a   MacPherson, Peter ^a,b   Jones, Kathy ^c   Hopkins, Mark ^c   Moorcroft, Jay ^c   Lalloo, David G ^a   Chawla, Anu ^c  

^a LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c ROYAL LIVERPOOL AND BROADGREEN UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN;

ADULT; ANTIBODY DETECTION; ANTIGEN ANTIBODY REACTION; ANTIGEN DETECTION; ARTICLE; COMMUNITY CARE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE RESULT; FEMALE; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; POINT OF CARE TESTING; POLYMERASE CHAIN REACTION; PUBLIC HEALTH SERVICE; QUANTITATIVE ANALYSIS; SCREENING TEST; SEROCONVERSION; SEXUAL HEALTH; DEMOGRAPHY; DIAGNOSTIC PROCEDURE; HEALTH CARE FACILITY; IMMUNOLOGY; MASS SCREENING; RISK FACTOR;

ADULT; DIAGNOSTIC TECHNIQUES AND PROCEDURES; FEMALE; HEALTH FACILITIES; HIV ANTIBODIES; HIV ANTIGENS; HIV INFECTIONS; HUMANS; MALE; MASS SCREENING; RESIDENCE CHARACTERISTICS; RISK FACTORS; YOUNG ADULT;

EID: 81555212324     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0028019     Document Type: Article

References (25)

1. Weber B, Meier T, Enders G, (2002) Fourth generation human immunodeficiency virus (HIV) screening assays with an improved sensitivity for p24 antigen close the second diagnostic window in primary HIV infection. Journal of Clinical Virology 25: 357-359.
2. Weber B, Orazi B, Raineri A, Thorstensson R, Burgisser P, et al. (2006) Multicenter evaluation of a new 4(th) generation HIV screening assay Elecsys HIV combi. Clinical Laboratory 52: 463-473.
3. Marum E, Taegtmeyer M, Chebet K, (2006) Scale-up of voluntary HIV counseling and testing in Kenya. JAMA 296: 859-862.
4. Prost A, Griffiths C, Anderson J, Wight D, Hart G, (2009) Feasibility and acceptability of offering rapid HIV tests to patients registering with primary care in London (UK): a pilot study. Sex Transm Infect 85: 326-329.
5. Surah S, O'Shea S, Dunn H, Mitra R, Fitzgerald C, et al. (2009) Utilization of HIV point-of-care testing clinics in general practice and genitourinary medicine services in south-east London. Int J STD AIDS 20: 168-169.
6. Pilcher CD, Christopoulos KA, Golden M, (2010) Public health rationale for rapid nucleic acid or p24 antigen tests for HIV. J Infect Dis 201 (Suppl 1): S7-15.
7. Beelaert G, Fransen K, (2010) Evaluation of a rapid and simple fourth-generation HIV screening assay for qualitative detection of HIV p24 antigen and/or antibodies to HIV-1 and HIV-2. J Virol Methods 168: 218-222.
8. Inverness Medical Innovations Inc (2010) Determine HIV-1/2 Ag/Ab Combo. Performance Data.
9. Fox J, Dunn H, O'Shea S, (2011) Low rates of p24 antigen detection using a fourth-generation point of care HIV test. Sex Transm Infect 87: 178-179.
10. Miller WC, Kampanga G, Phiri S, Nsona D, Rosenburg NE, et al. (2011) 18th Conference on Retroviruses and Opportunistic Infections Boston, USA.
11. Sudarshi D, Pao D, Murphy G, Parry J, Dean G, et al. (2008) Missed opportunities for diagnosing primary HIV infection. Sex Transm Infect 84: 14-16.
12. Health Protection Agency UK (2008) Diagnosed HIV prevalence by Strategic Health Authority (SHA) and Primary Care Trust (PCT) in England, 2008.
13. Health Protection Agency UK (2009) HIV in the United Kingdom: 2009 Report London.
14. Thomas S, Ratcliff L, Beeching N, Taegtmeyer M, (2009) Comparison of acute hospital presentations of patients during two time periods (1983-2001 and 2005-2007): opportunities for early diagnosis are still being missed. HIV Medicine 10 (Suppl 1) 48 Abstract no. 116.
15. World Health Organization (2007) Guidance on Provider-Initiated HIV Testing and Counselling in Health Facilities Geneva.
16. MacPherson P, Chawla A, Jones K, Coffey E, Spaine V, et al. (2011) Feasibility and acceptability of point of care HIV testing in community outreach and GUM drop-in services in the North West of England: a programmatic evaluation. BMC Public Health 11: 419.
17. Merson MH, O'Malley J, Serwadda D, Apisuk C, (2008) The history and challenge of HIV prevention. Lancet 372: 475-488.
18. Burns FM, Johnson AM, Nazroo J, Ainsworth J, Anderson J, et al. (2008) Missed opportunities for earlier HIV diagnosis within primary and secondary healthcare settings in the UK. AIDS 22: 115-122.
19. Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG, (2009) Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet 373: 48-57.
20. Napierala Mavedzenge S, Baggaley R, Ru Lo Y, Corbett E, World Health Organization (2011) HIV self-testing among health workers. A review of the literature and discussion of current practices, issues and options for increasing access to HIV testing in sub-Saharan Africa Geneva.
21. Obermeyer CM, Osborn M, (2007) The utilization of testing and counseling for HIV: a review of the social and behavioral evidence. Am J Public Health 97: 1762-1774.
22. British HIV Association HIV (2008) British Association for Sexual Health & HIV and British Infection Society. UK National Guidelines for HIV Testing.
23. Branson BM, Handsfield HH, Lampe MA, Janssen RS, Taylor AW, et al. (2006) Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep 55: 1-17.
24. Pilcher CD, Louie B, Keating S, Pandori M, Fish F, et al. (2009) A clinical study of antigen-antibody rapid testing for acute HIV infection. 18th Conference on Retroviruses and Opportunistic Infections, Montreal, Canada.
25. U.S. Public Health Service guidelines for testing and counseling blood and plasma donors for human immunodeficiency virus type 1 antigen (1996) MMWR Recomm Rep 45: 1-9.